Pacific Biosciences Targeting $15-$17 Share Price for IPO | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences will make 12.5 million shares available at a price between $15 and $17 per share for its initial public offering, the company said in an amended preliminary prospectus filed with the US Securities Exchanged Commission today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.